Association of the T allele of an intronic single nucleotide polymorphism in the colony stimulating factor 1 receptor with Crohn's disease: A case-control study

Journal of Immune Based Therapies and Vaccines

Volumn 2, Issue , 2004, Pages

  Zapata Velandia, Adriana ^a   Ng, San San ^a   Brennan, Rebecca F ^a   Simonsen, Neal R ^b   Gastanaduy, Mariella ^a   Zabaleta, Jovanny ^a   Lentz, Jennifer J ^a   Craver, Randall D ^a   Correa, Hernan ^a   Delgado, Alberto ^a   Pitts, Angela L ^a   Himel, Jane R ^a   Udall Jr , John N ^a   Schmidt Sommerfeld, Eberhard ^a   Brown, Raynorda F ^a   Athas, Grace B ^a   Keats, Bronya B ^a   Mannick, Elizabeth E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; COLONY STIMULATING FACTOR RECEPTOR; GENOMIC DNA; MULTIDRUG RESISTANCE PROTEIN 1; PARAFFIN; POLYCLONAL ANTIBODY; TRANSCRIPTION FACTOR RUNX1;

ALLELE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CHROMOSOME 5Q; CONTROLLED STUDY; CROHN DISEASE; DNA SEQUENCE; GENE EXPRESSION; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNITY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INFORMED CONSENT; INTRON; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; PROTEIN TARGETING; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SECTION;

EID: 4243108256     PISSN: 14768518     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-8518-2-6     Document Type: Article

References (36)

1. Pallone F, Blanco Gdel V, Vavassori P, Monteleone I, Fina D, Monteleone G: Genetic and pathogenetic insights into inflammatory bowel disease. Curr Gastroenterol Rep 2003, 5:487-92.
2. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karalluskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
3. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Moraln CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbalou M, Thomas G: Association of NOD2 leucine- rich repeat variants with susceptibility to Crohn's disease. Nature 2001, 411:599-603.
4. Inohara N, Ogura Y, Fontalba A, Guttierrez O, Pons F, Crespo J, Fukase K, Inamura S, Kusumoto S, Hashimoto M, Foster SJ, Moran AP, Fernandez-Luna JL, Nunez G: Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem 2003, 278:5509-12.
5. Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, Greenson JK, Keshav S, Nunez G: Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 2003, 52:591-7.
6. Brant SR, Panhuysen CI, Nicolae D, Reddy DM, Bonen DK, Karaliukas R, Zhang L, Swanson E, Datta LW, Moran T, Ravenhill G, Duerr RH, Achkar JP, Karban AS, Cho JH: MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet 2003, 73:1282-92.
7. Schwab M, Schaeffeler E, Marx C, Fromm MF, Kaskas B, Metzler J, Stange E, Herfarth H, Schoelmerich J, Gregor M, Walker S, Cascorbi I, Roots I, Brinkmann U, Zanger UM, Eichelbaum M: Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003, 124:26-33.
8. Panwala CM, Jones JC, Viney JL: A novel model of inflammatory bowel disease: mice deficient fro the multiple drug resistance gene, mdr1a, spontaneously develop colitis. J Immunol 1998, 161:5733-5744.
9. Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Green T, Brettin TS, Stone V, Bull SB, Bitton A, Williams CN, Greenberg GR, Cohen Z, Lander ES, Hudson TJ, Siminovitch KA: Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000, 66:1863-70.
10. Rioux JD, Daly MJ, Silverberg MS, Lindblad K, Steinhart H, Cohen Z, Delmonte T, Kocher K, Miller K, Guschwan S, Kulbokas EJ, O'Leary S, Winchester E, Dewar K, Green T, Stone V, Chow C, Cohen A, Longelier D, Lapointe G, Gaudet D, Faith J, Branco N, Bull SB, McLeod RS, Griffiths AM, Bitton A, Greenberg GR, Lander ES, Siminovitch KA, Hudson TJ: Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001, 29:223-8.
11. Peltekova VD, Wintle RF, Rubin LA, Amos CI, Huang Q, Gu X, Newman B, Van Oene M, Cescon D, Greenberg G, Griffiths AM, St George-Hyslop PH, Siminovitch KA: Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 2004, 36:471-5.
12. Tokuhiro S, Yamada R, Chang X, Suzuki A, Kochi Y, Sawada T, Suzuki M, Nagasaki M, Ohtsuki M, Ono M, Furukawa H, Nagashima M, Yoshino S, Mabuchi A, Sekine A, Saito S, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K: An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 2003, 35:341-8.
13. Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, Eitner K, Marx M, Duerig N, Epplen JT: A polymorphism in the CD14 gene is associated with Crohn disease. Scand J Gastroenterol 2002, 37:189-91.
14. Riccioni R, Saulle E, Militi S, Sposi NM, Gualtiero M, Mauro N, Mancini M, Diverio D, Lo Coco F, Peschle C, Testa U: C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia. Leukemia 2003, 17:98-113.
15. Sapi E, Flick MB, Rodov S, Carter D, Kacinski BM: Expression of CSF-1 and CSF-1 receptor by normal lactating mammary epithelial cells. J Soc Gynecol Investig 1998, 5:94-101.
16. Buaknecht T, Kiechle-Schwarz M, du Bois A, Wolfle J, Kacinski B: Expression of transcripts for CSF-1 and for the "macrophage" and "epithelial" isoforms of the CSF-1R transcripts in human ovarian carcinomas. Cancer Detect Prev 1994, 18:231-9.
17. Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW: The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma. Clin Cancer Res 1995, 1:313-25.
18. Ide H, Seligson DB, Memarzadeh S, Xin L, Horvath S, Dubey P, Flick MB, Kacinski BM, Palotie A, Witte ON: Expression of colonystimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci U S A 2002, 99:14404-9.
19. Nemunaitis J, Shannon-Dorcy K, Appelbaum FR, Meyers J, Owens A, Day R, Ando D, O'Neill C, Buckner D, Singer J: Long-term followup of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. Blood 1993, 82:1422-7.
20. Jin Y, Dons L, Kristensson K, Rottenberg ME: Colony-stimulating factor 1-dependent cells protect against systemic infection with Listeria monocytogenes but facilitate neuroinvasion. Infect Immun 2002, 70:4682-6.
21. i2 proteins of v-fms-induced proliferation and transformation via Srckinase and STAT3. Oncogene 1999, 18:6335-6342.
22. Rudolph U, Finegold MJ, Rich SS, Harriman GR, Srinivasan Y, Brabet P, Boulay G, Bradley A, Birnbaumer L: Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice. Nat Genet 1995, 10:143-50.
23. Welte T, Zhang SS, Wang T, Zhang Z, Hesslein DG, Yin Z, Kano A, Iwamoto Y, Li E, Craft JE, Bothwell AL, Fikrig E, Koni PA, Flavell RA, Fu XY: STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity. Proc Natl Acad Sci U S A 2003, 100:1879-84.
24. Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S: Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999, 10:39-49.
25. Ridge SA, Worwood M, Oscier D, Jacobs A, Padua RA: FMS mutations in myelodysplastic, leukemic, and normal subjects. Proc Natl Acad Sci U S A 1990, 87:1377-1380.
26. Dombret H, Marolleau JP: De novo acute myeloid leukemia in patients with Crohn's disease. Nouv Rev Fr Hematol 1995, 37:193-6.
27. Harewood GC, Loftus EV Jr, Tefferi A, Tremaine WJ, Sandborn WJ: Concurrent inflammatory bowel disease and myelodysplastic syndromes. Inflamm Bowel Dis 1999, 5:98-103.
28. Heisterkamp N, Groffen J, Stephenson JR: Isolation of v-fms and its human cellular homolog. Virology 1983, 126:248-58.
29. Pixley FJ, Lee PSW, Condeelis JS, Stanley ER: Protein tyrosine phosphatase φ regulates paxillin tyrosine phosphorylation and mediates colony stimulating factor 1-induced morphological changes in macrophages. Mol Cell Biol 2001, 21:1795-1809.
30. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP, EPWG-IBD Group, EPIMAD Group, GETAID Group: CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002, 70:845-57.
31. Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, Fischel- Ghodsian N, Targan SR, Rotter JI, Yang H: A novel NOD2/ CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Human Genet 2003, 72:509-18.
32. Croucher PJ, Mascheretti S, Hampe J, Huse K, Frenzel H, Stoll M, Lu T, Nikolaus S, Yang SK, Krawczak M, Kim WH, Schreiber S: Haplotype structure and association to Crohn's diseas of CARD15 mutations in two ethnically divergent populations. Eur J Hum Genet 2003, 11:6-16.
33. Nielsen C, Hansen D, Husby S, Jacobsen BB, Lellevang ST: Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes. Tissue Antigens 2003, 62:492-7.
34. Helms C, Cao L, Krueger JG, Wijsman EM, Chamian F, Gordon D, Heffernan M, Daw JA, Robarge J, Ott J, Kwok PY, Menter A, Bowcock AM: A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 2003, 35:349-56.
35. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Broookes AJ, Tentler D, Kristiansdottir H, Grondal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jonssen A, Truedsson L, Lima G, Alcocer-Varela J, Johsson R, Gyllensten UB, Harley JB, Alarcon-Segovia D, Steinsson K, Alarcon-Riquelme ME: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002, 32:666-9.
36. Fears S, Gavin M, Zhang DE, Hetherington C, Ben-David Y, Rowley JD, Nucifora G: Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. Proc Natl Acad Sci USA 1997, 94:1949-1954.